XML 15 R4.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Mar. 31, 2025
Mar. 31, 2024
Defined Benefit Plan Disclosure [Line Items]        
Total revenue $ 1,837,442 $ 44,243 $ 3,438,384
Cost of revenue 649,491 128,584 2,038,219
Gross profit (loss) 1,187,951 (84,341) 1,400,165
Operating expenses        
Share-based compensation 829,292 1,676,659
General and administrative 115,386 404,541 603,950 647,429
Total operating expenses 944,678 404,541 2,280,609 647,429
Income (loss) from operations (944,678) 783,410 (2,364,950) 752,736
Other expense        
Interest expense, net (6,817) (6,008) (22,091) (17,353)
Other expense, net 688 (110,221) (9,527)
Total other expense, net (6,129) (6,008) (132,312) (26,880)
Income (loss) before income taxes (950,807) 777,402 (2,497,262) 725,856
Income tax provision 167,237 738 168,768
Net income (loss) from continuing operations (950,807) 610,165 (2,498,000) 557,088
Net income from discontinued operations 1,859,207
Net income (loss) (950,807) 610,165 (2,498,000) 2,416,295
Other comprehensive income (loss)        
Foreign currency translation adjustment 2,061 1,835 6,291 (17,466)
COMPREHENSIVE INCOME (LOSS) $ (948,746) $ 612,000 $ (2,491,709) $ 2,398,829
Weighted average common stock outstanding        
Basic 27,410,921 26,657,921 27,159,096 26,657,921
Diluted 27,410,921 [1] 27,489,921 [1] 27,159,096 [1] 27,489,921
Net income (loss) from per share of common stock – Basic $ (0.03) $ 0.02 $ (0.09) $ 0.09
Net income (loss) from per share of common stock – Diluted $ (0.03) $ 0.02 $ (0.09) $ 0.09
Nonrelated Party [Member]        
Defined Benefit Plan Disclosure [Line Items]        
Total revenue $ 1,837,442 $ 3,438,384
Related Party [Member]        
Defined Benefit Plan Disclosure [Line Items]        
Total revenue $ 44,243
[1] Net loss per share was the same for the basic and diluted weighted average shares outstanding for the three and nine months ended March 31, 2025 due to anti-dilution feature resulting from the net loss.